STERIS plc (NYSE:STE – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $258.75.
STE has been the subject of several recent research reports. Stephens reaffirmed an “overweight” rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 6th.
View Our Latest Research Report on STERIS
Institutional Investors Weigh In On STERIS
STERIS Price Performance
Shares of NYSE STE opened at $227.04 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS has a twelve month low of $197.82 and a twelve month high of $248.24. The stock has a 50 day moving average of $219.17 and a two-hundred day moving average of $222.48. The stock has a market cap of $22.31 billion, a P/E ratio of 48.20 and a beta of 0.92.
STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts forecast that STERIS will post 9.08 earnings per share for the current year.
STERIS Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Further Reading
- Five stocks we like better than STERIS
- How to Use the MarketBeat Excel Dividend Calculator
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 10 Best Airline Stocks to Buy
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.